t-cells

Documents about t-cells

• T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies#1033524ClinicalTrials.gov
• Supplementary file 1_Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.docx#361735Figshare
• PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer#140987ClinicalTrials.gov
• TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases.#170676NCBI PubMed Central
• Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin#311123ClinicalTrials.gov
• NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma#349970ClinicalTrials.gov
• Stem Cell Therapy for Traumatic Brain Injury: Translational Mechanisms, Biomarkers, and Clinical Trials#359194Springer Nature OA
• HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma#363619ClinicalTrials.gov
• Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease#414505ClinicalTrials.gov
• Functional heterogeneity and plasticity in naïve CD8 T cells drive superior effector and memory responses#629499Europe PMC
• Pan-immune single-cell perturbation datasets used in PolarisT#784716Figshare
• To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients#840623ClinicalTrials.gov
• Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease#851290ClinicalTrials.gov
• A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia#856671ClinicalTrials.gov
• A Phase I Dose Finding Study of MB-CART2219.1#858829ClinicalTrials.gov
• CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies#878848ClinicalTrials.gov
• Long-Term Follow-up Study for Patients Previously Treated With JCAR015#880935ClinicalTrials.gov
• A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients#895811ClinicalTrials.gov
• A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia#896249ClinicalTrials.gov
• Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19#910782ClinicalTrials.gov
• CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19#912403ClinicalTrials.gov
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies#858972ClinicalTrials.gov
• Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia#871638ClinicalTrials.gov
• A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells#935018Koc University Digital Collections
• NOS2 and COX2 impact the spatial landscape of CD8(+) T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival.#170674NCBI PubMed Central
• Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectives#266486Europe PMC
• The role of mucosal-associated invariant T (MAIT) cells in long-term resistance to Mycobacterium tuberculosis (M.tb) infection in healthcare workers with sustained occupational exposure to TB#316269OpenUCT
• Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies#435725ClinicalTrials.gov
• Establishment of a scalable engineered cell-line platform for direct, GMP-grade production of eVLP vectors enabling streamlined generation of gene-edited CAR-T/NK cells.#446228NCBI PubMed Central
• Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers#450666S-Space: Seoul National University
• Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis#453450Spiral
• EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells#472072IRIS
• CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#485300Europe PMC
• Electronic fuse (e-fuse) cells integrated with bipolar device — Globalfoundries U.S. Inc. (US11322497B1)#607319Google Patents
• Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers.#631510PubMed
• Modeling of ex vivo immune response reveals a central role for CD8(+)CD25(+) cells in Adult T-cell Leukemia survival: a long-term prospective cohort study.#666134NCBI PubMed Central
• Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma#801583ClinicalTrials.gov
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)#833241ClinicalTrials.gov
• Predictive Value of Th1, Th2 and Th17 Cytokines on the Success of Embryo Implantation (ImmuNoFertilité)#860608ClinicalTrials.gov
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases#867916ClinicalTrials.gov
• Ebola and Marburg Virus Vaccines#901254ClinicalTrials.gov
• Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis#915807ClinicalTrials.gov
• Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA#917585ClinicalTrials.gov
• Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL#884687ClinicalTrials.gov
• Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)#888357ClinicalTrials.gov
• Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL#1010889ClinicalTrials.gov
• Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias#184921ClinicalTrials.gov
• A major histocompatibility complex (MHC) class II molecule that binds the same viral pathogen peptide with both nonamer and decamer core sequences for presentation to T cells.#209538NCBI PubMed Central
• Optoelectronics#359814DOAB PROD Instance
• Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies#398314ClinicalTrials.gov